Quarterly report · Q2
3401.TEDINET S100S6J7
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥506.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥1.02T | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥510.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥10.0bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥14.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥10.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥9.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥20.0bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥8.7bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥19.8bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥541m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥17.7bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥7.6bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥742m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥8.7bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥1.32T | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥1.24T | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.31T | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥848.4bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥791.3bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥472.3bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥451.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥482.9bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥155.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥142.8bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥152.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥140.3bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥130.7bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥23.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥55.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥32.1bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥27.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥52.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥29.8bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥14.0bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥7.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥18.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-2.81 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-12.46 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-92.04 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥39.41 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.59 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥39.34 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 33.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.2% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.1% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 39
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥29.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥27.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | −¥530m |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥70.7bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥70.7bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥8.2bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥220.5bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥215.5bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥5.0bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥5.3bn |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥488.3bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥479.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥9.3bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥14.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥518.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥506.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥13.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥26.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥24.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥2.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | −¥693m |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥77.9bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥77.9bn |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥0 |
| jpcrp040300-q2r_E00872-000Healthcarereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥15.3bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥227.7bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥222.6bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥5.1bn |
| jpcrp040300-q2r_E00872-000Materialreportable segment | segment profit | 2022-04-01 → 2022-09-30 | −¥5.8bn |
| —segment total | revenue | 2022-04-01 → 2022-09-30 | ¥495.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-09-30 | ¥486.3bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥9.5bn |
| —segment total | segment profit | 2022-04-01 → 2022-09-30 | ¥18.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥522.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥510.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥11.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥17.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 566
| Item | Context | Value | Unit |
|---|---|---|---|
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -5549000000 | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YTDDuration | 282000000 | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYTDDuration | 183000000 | JPY |
| Insurance income ope cf | Prior1YTDDuration | － | JPY |
| Insurance income ope cf | CurrentYTDDuration | -1636000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | 9872000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -1765000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -29475000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -20130000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | 2435000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -5138000000 | JPY |
| Other net ope cf | Prior1YTDDuration | 5817000000 | JPY |
| Other net ope cf | CurrentYTDDuration | -862000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 41609000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | 19468000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 3906000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 4999000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -2717000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -4954000000 | JPY |
| Income taxes paid refund ope cf | Prior1YTDDuration | -10665000000 | JPY |
| Income taxes paid refund ope cf | CurrentYTDDuration | 2441000000 | JPY |
| Proceeds from insurance income ope cf | Prior1YTDDuration | － | JPY |
| Proceeds from insurance income ope cf | CurrentYTDDuration | 1636000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 32132000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 23590000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -26736000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -27839000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | Prior1YTDDuration | 50000000 | JPY |
| Proceeds from sales of property plant and equipment inv cf | CurrentYTDDuration | 12000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -1364000000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -1780000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -1212000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -3881000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 1825000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 8857000000 | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | Prior1YTDDuration | － | JPY |
| Purchase of investments in subsidiaries resulting in change in scope of consolidation inv cf | CurrentYTDDuration | -1332000000 | JPY |
| Net decrease increase in short term loans receivable inv cf | Prior1YTDDuration | -512000000 | JPY |
| Net decrease increase in short term loans receivable inv cf | CurrentYTDDuration | -683000000 | JPY |
| Other net inv cf | Prior1YTDDuration | -1866000000 | JPY |
| Other net inv cf | CurrentYTDDuration | -926000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -29815000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -27573000000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | 26853000000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | 25394000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -1643000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -6728000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -2000000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -4000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -5283000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |